Clarus (NASDAQ:CLAR – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a note issued to investors on Saturday. Other research analysts have also recently issued research reports about the stock. Zacks Research cut shares of Clarus from a “strong-buy” rating to a […]

Intapp (NASDAQ:INTA – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. A number of other research firms have also recently weighed in on INTA. Zacks Research cut Intapp from a “hold” rating to a “strong sell” […]

Solstice Advanced Mat (NASDAQ:SOLS – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday. Other equities research analysts have also issued reports about the company. Royal Bank Of Canada lowered their price objective on Solstice […]

Willdan Group (NASDAQ:WLDN – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued on Saturday. WLDN has been the subject of several other research reports. Zacks Research lowered Willdan Group from a “strong-buy” rating to a “hold” rating in […]

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday. Several other equities analysts have also issued reports on PTGX. Weiss Ratings reissued a “sell (d+)” rating on shares of Protagonist Therapeutics in […]